Your browser doesn't support javascript.
loading
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Chacón López-Muñiz, JI; Cruz Merino, L de la; Gavilá Gregori, J; Martínez Dueñas, E; Oliveira, M; Seguí Palmer, MA; Álvarez López, I; Antolin Novoa, S; Bellet Ezquerra, M; López-Tarruella Cobo, S.
Afiliação
  • Chacón López-Muñiz, JI; Hospital Virgen de la Salud. Servicio de Oncología Médica. Toledo. Sapin
  • Cruz Merino, L de la; University of Sevilla. Hospital Virgen Macarena. Medicine Department. Servicio de Oncología Médica. Seville. Spain
  • Gavilá Gregori, J; Fundación Instituto Valenciano de Oncología. Servicio de Oncología Médica. Valencia. Spain
  • Martínez Dueñas, E; Hospital Provincial de Castellón. Servicio de Oncología Médica. Castellón. Spain
  • Oliveira, M; Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology. Barcelona. Spain
  • Seguí Palmer, MA; Corporació Sanitaria Parc Tauli. Servicio de Oncología Médica. Sabadell. Spain
  • Álvarez López, I; Hospital Universitario Donostia/Donostiako Unibertsitate Ospitalea. Servicio de Oncología Médica. Donostia. Spain
  • Antolin Novoa, S; Hospital Universitario A Coruña. Servicio de Oncología Médica. A Coruña. Spain
  • Bellet Ezquerra, M; Vall d'Hebron University Hospital. Vall d'Hebron Institute of Oncology (VHIO). Barcelona. Spain
  • López-Tarruella Cobo, S; Hospital General Universitario Gregorio Marañón. Servicio de Oncología Médica. Madrid. Spain
Clin. transl. oncol. (Print) ; 21(1): 31-45, ene. 2019. tab
Article em En | IBECS | ID: ibc-183342
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
Although the metastasic breast cancer is still an incurable disease, recent advances have increased significantly the time to progression and the overall survival. However, too much information has been produced in the last 2 years, so a well-based guideline is a valuable document in treatment decision making. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with advanced and recurrent breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference
RESUMEN
No disponible
Assuntos

Texto completo: 1 Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias da Mama / Metástase Neoplásica / Recidiva Local de Neoplasia Limite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 06-national / ES Base de dados: IBECS Assunto principal: Neoplasias da Mama / Metástase Neoplásica / Recidiva Local de Neoplasia Limite: Female / Humans Idioma: En Revista: Clin. transl. oncol. (Print) Ano de publicação: 2019 Tipo de documento: Article
...